Last reviewed · How we verify

NCT03732417

Telematic Model Integrated in the Transversal Care of the Secondary Prevention of Patients With Stroke

Withdrawn Last updated 14 February 2024
What this trial tests

trial testing Secondary prevention of cardiovascular risk factors in Stroke. Withdrawn.

Timeline
1 October 2021
Primary endpoint
1 October 2021
31 December 2023

Quick facts

Lead sponsorInstitut Investigacio Sanitaria Pere Virgili
StatusWithdrawn
Study typeOBSERVATIONAL
Start date1 October 2021
Primary completion1 October 2021
Estimated completion31 December 2023
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Institut Investigacio Sanitaria Pere Virgili — full company profile →

Who can join

18 and older, any sex, with Stroke or Risk Factor, Cardiovascular. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In Spain, stroke is the leading cause of death in women and disability in adults, which is why it is currently one of the most important public health problems. It is known that the main cause of stroke is the lack of control of cardiovascular risk factors (CRF). Strategies have been diversified for patients with severe neurological involvement, while those without or with mild involvement, susceptible to repeat a stroke, have a very heterogeneous approach. Objective: Design, implement and evaluate the effectiveness of the transversal telematic model of secondary prevention in patients who have suffered a stroke. Methodology: Randomized clinical trial with a control group, open and multicentre. A total of 70 patients (35 per group) will be included who meet all the inclusion criteria and none of exclusion, attended by an acute stroke in the Hospital Verge de la Cinta de Tortosa. Variables: sociodemographic and clinical, FRC, stage of change, therapeutic compliance and CV. Outcome variables: impact of the stroke using the scale (SIS-16); control of CRF, new vascular events and mortality at 3, 6, 12, 18 and 24 months, integrable in the practice and computerized clinical history (HCI). Interventions: control and education for the patient's health to promote self-care and empowerment, and enhance pharmacological compliance. The telematic model has been developed through clinical practice guides of primary care and the most recent publications on the subject referenced. Export of data directly from the HCI. Analysis of results with the SPSS 23.0 program, using regression and survival models.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other Institut Investigacio Sanitaria Pere Virgili trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03732417.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing